What’s New in Cardiovascular Disease

News
Slideshow

As the new year begins, several developments in heart health research are making the news.

Newsletter

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Subscribe Now!
Recent Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Related Content
Oral PCSK9 Inhibitor Enlicitide Meets All Endpoints in Phase 3 Hypercholesterolemia Trial

Oral PCSK9 Inhibitor Enlicitide Meets All Endpoints in Phase 3 Hypercholesterolemia Trial

Patient Care Editorial Staff
September 3rd 2025
Article
Weekly Dose Podcast: CRC Screening Uptake, GLP-1 Eligibility in Youth, Women’s Heart Health, and Ultraprocessed Food Risks

Weekly Dose Podcast: CRC Screening Uptake, GLP-1 Eligibility in Youth, Women’s Heart Health, and Ultraprocessed Food Risks

Sydney Jennings
September 3rd 2025
Podcast
American College of Cardiology: How to Address Barrier to Immunization for Adults with CVD / image credit ©MAKOVSKY ART/stock.adobe.com

American College of Cardiology: How to Address Barriers to Immunization for Adults with CVD

Grace Halsey
September 3rd 2025
Article
The Weekly Dose: Clinical Updates on Cancer Detection, Cognitive Screening, CVD Prevention, Atopic Dermatitis Treatment

The Weekly Dose: Clinical Updates on Cancer Detection, Cognitive Screening, CVD Prevention, Atopic Dermatitis Treatment

Sydney Jennings
September 3rd 2025
Podcast
FDA Expands Evolocumab Indication to Adults at Risk for Major Cardiovascular Events Due to Uncontrolled LDL-C

FDA Expands Evolocumab Indication to Adults at Risk for Major Cardiovascular Events Due to Uncontrolled LDL-C

Sydney Jennings
September 3rd 2025
Article
Excess Intake of Ultraprocessed Foods Tied to Higher Cardiometabolic Risk: Daily Dose / image credit: ©New Africa/AdobeStock

Excess Intake of Ultraprocessed Foods Tied to Higher Cardiometabolic Risk: Daily Dose

Sydney Jennings
September 3rd 2025
Article
© 2025 MJH Life Sciences

All rights reserved.